WEST LAFAYETTE, Ind. — A researcher in Purdue University’s College of Science is developing a patent-pending platform technology that mimics the dual-layer structure of viruses to deliver nucleic acid ...

Recent developments in nanoparticle-mediated cancer immunotherapy promote treatment with less toxicity. Cancer immunotherapy utilizes a patient’s immune system to target and destroy cancer. Many types ...

Not all symptoms or signs occur in all cases and there are febrile or meningoencephalitic forms of some of the diseases (e.g., TBEV), which present and progress differently. For several of these ...

This is a preview. Log in through your library . Abstract Type I interferons (IFNs) are innate immune cytokines required to establish cellular host defense. Precise control of IFN gene expression is ...

A researcher is developing a patent-pending platform technology called LENN that mimics the dual-layer structure of viruses to deliver nucleic acid (NA)-based therapies to targeted cancer cells. A ...

Purdue University researcher David Thompson has developed LENN, a system to deliver nucleic acid-based therapies to targeted cancer cells. His and his team’s research into using LENN to deliver ...